Find in Library

Samit GhosalDepartment of Endocrinology, Nightingale Hospital, Kolkata, IndiaI read with interest the “Thorough QTc study” with teneligliptin by Erande et al.1 It came as a surprise to me that the basic structure required to conduct such a trial as per the ICH E14 recommendations for the industry was not followed.2 The recommended design to conduct such a trial was not universally followed (Table1).View the original paper by Erande and colleagues